AI Maverick Intel, Inc., formerly Bionoid Pharma, Inc., is an artificial intelligence (AI) company focused on acquiring and enhancing software solutions that leverage AI and automation to optimize customer acquisition and audience engagement. The Company’s principal asset is its AI Maverick Intel platform, which is designed to automate and enhance customer acquisition processes using machine learning, behavioral data analysis, and performance-driven optimization. The technology enables intelligent, two-way communication and data-driven engagement across healthcare, biotech, and other sectors. It is also focused on Software-as-a-Service (SaaS) licensing, enterprise integration, and consulting services based on its AI technology stack.